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Summary  The  diagnosis  and  management  of  prosthetic  joint  infections  (PJI)  with
negative  cultures  remains  an  enigma  without  clear  deﬁnitions  and  guidelines  for
its  management.  In  contrast,  the  literature  offers  guidelines  to  the  diagnosis  and
management  of  culture  positive  prosthetic  joint  infections  as  noted  in  both  the
infectious  disease  literature  and  the  orthopedic  literature.
This  paper  outlines  the  current  state  of  knowledge  of  PJI  with  negative  cultures
and  summarizes  the  recommendations  for  the  work  up  and  management  of  this
condition.  In  addition,  we  propose  a  simple  algorithm  that  clinicians  may  ﬁnd  useful
for  the  management  of  PJI  with  negative  cultures.  This  algorithm  has  not  been
validated  with  data  at  this  point,  but  can  be  applied  to  practice  to  help  direct  the
management  and  diagnosis  of  prosthetic  joint  infections  in  the  absence  of  positive
cultures.
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Table  1.1  Microbiology  of  culture-positive  PJI
[1,3—16].
Gram-positive  >50%
•  Staphylococcus  aureus • 24—43%
•  Coagulase-negative  staphylococcus  •  12—26%
Gram-negative  3—10%
•  Enterobacter  spp.  •  78%
•  Pseudomonas  spp.  •  20%
•  Escherichia  coli
•  Klebsiella  spp.
•  Proteus  spp.
Anaerobes  2—4%
Mycobacterium  0.7%
Fungi  1.2%
Polymicrobial  10%
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Introduction
Prosthetic  joint  infections  pose  an  increased  prob-
lem for  physicians  due  to  the  lack  of  standardized
guidelines.  The  risk  of  an  implant  infection  is  high
in the  ﬁrst  2  years,  but  remains  a  lifelong  risk  and  is
related to  the  presence  of  a  bioﬁlm  [1,2].  The  cur-
rent guidelines  attempt  to  address  prosthetic  joint
infections  (PJI)  caused  by  the  most  common  bacte-
ria as  seen  in  Table  1.1  [1,3—16], but  fail  to  address
PJI with  negative  cultures.  In  addition,  the  type  of
prosthetic  joint  infection  is also  an  additive  factor.
In the  early  post-operative  infections,  antibiotics
play an  important  role  in  detection  of  the  organism,
while in  the  later  chronic  infections,  other  factors
such as  fastidious  organisms,  patchy  distribution  of
infection, low  inoculum  of  infection,  and  the  pres-
ence of  non-recoverable  bioﬁlm  embedded  bacteria
also play  a  role  in  making  the  diagnosis  difﬁcult
[5,9,17].  This  paper  aims  to  address  the  risk  fac-
tors, pathogenesis  and  diagnostic  approach  for  this
group of  patients.  We  have  also  included  a  proposal
for an  algorithm  for  the  approach  and  management
of these  patients.
EpidemiologyIn 2014,  over  one  million  total  prosthetic  surgeries
were performed  worldwide  with  an  incidence  of
prosthetic  joint  infections  ranging  from  1  to  4%
1
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tfter  primary  knee  replacement  and  1  to  2%  after
rimary  hip  replacement  [18,19]. Approximately
5—20% of  all  prostheses  are  found  to  be  infected
fter primary  revision  surgeries  [4,5].
Organism  isolated  from  culture-positive  speci-
ens is  shown  in  Table  1.1  [1,3—16], Gram-positive
acteria account  for  over  50%  of  all  prosthetic  joint
nfections.  Staphylococcus  aureus  and  coagulase-
egative staphylococci  are  the  two  most  common
rganisms with  incidence  rates  of  24—43%  and
2—26%, respectively  [4,5,7].  In  addition,  it  has
een found  that  Streptococci  occur  in  8—10%,
nterococci in  3—7%,  and  Corynebacterium  diph-
heria in  2%  of  all  PJI  [5,7,11].
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Table  1.2  Microbiology  of  percentages  culture-
negative  PJI  [8,17,20—24].
Fungi  46%
Mycobacteria  43%
Other  11%
•  Brucella
• Coxiella  burnetii
• Lactobacillus  spp.
•  Listeria  monocytogenes
• Pasteurella  multocida
•  Propionibacterium  acnes
•  Pseudomonas  spp.a
•  Serratia  marcescens
• Staphylococcusa
Streptococcusa
•  Tropheryma  whipplei
•  Ureaplasma  parvum
a Bacteria that cause a bioﬁlm have been shown to be
an independent risk factor for treatment failure and cause
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Gram-negative  bacilli,  although  not  as  common,
ccur in  3—10%  of  PJI  cases  [5,7,8].  Escherichia
oli, Enterobacter  spp.,  Pseudomonas  spp.,  Proteus
pp., and  Klebsiella  spp.  are  some  of  the  most  com-
on Gram-negative  bacteria  associated  with  PJI
12].  A  study  of  242  Gram-negative  PJI  cases,  78%
ere Enterobacter  spp.  and  20%  Pseudomonas  spp.
5].  Anaerobes  have  been  found  to  account  for  only
—4% of  all  PJI  [1]. Gram-negative  infections  and
naerobes  are  a  risk  for  treatment  failure  and  have
een found  to  require  longer  treatment  durations
ompared to  Gram-positive  infections  [5].  Gram-
egatives  and  anaerobes  have  been  associated  with
ate-onset  infections  from  hematogenous  spread
rom  a  secondary  infection  and  frequently  present
fter gastrointestinal  or  genitourinary  tract  proce-
ures [5,13].
Mycobacterium  spp.  and  fungi,  speciﬁcally  Can-
ida spp.  and  Aspergillus  spp.,  are  other  causative
rganisms  that  are  associated  with  a  delay  in  PJI
iagnosis  and  also  often  result  in  treatment  failure
5,14].  Bracken  et  al.  reported  an  incidence  rate  of
.2% for  fungal  PJI  out  of  3822  culture-positive  PJI
ases [15].  An  extensive  literature  review  in  2013  of
ll reported  Mycobacterium  tuberculosis  PJI  cases
eported  from  January  1950  to  July  2012  found
nly 15  cases  identiﬁed  worldwide  with  an  inci-
ence  rate  of  0.7%  [16].  Mycobacterium  spp.  and
ungal infections  are  most  often  associated  with
n immunocompromised  state  and  can  often  pre-
ipitate  a  culture-negative  diagnosis  due  to  a lack
f proper  isolation  of  the  organisms,  so  these  inci-
ence rates  are  likely  underreported  [10].  Overall,
olymicrobial  infections  account  for  10%  of  all  PJI’s
1].
Prosthetic  joints  with  negative  cultures  are
hown in  Table  1.2  [8,17,20—24]. These  infections
ccount for  5—12%  of  all  PJI  [9,25,26]  with  98%  of
hem related  speciﬁcally  to  knee  and  hip  arthro-
lasties [17].
athogenesis of PJI with negative
ultures
ulture-negative  PJI  account  for  10%  of  all  pros-
hetic joint  infections  [8,17].  This  can  be  compared
o the  cases  of  culture-negative  endocarditis  that
ccount for  20%  of  all  endocarditis  cases  [8,17].
hese infections  are  often  a  result  of  inaccu-
ate and  inappropriate  diagnostic  tools  for  fungal,
oonotic,  and  fastidious  bacteria  that  are  not  eas-
ly detected  routinely.  Million  et  al.  found  that
6% of  culture-negative  prosthetic  joint  infec-
ions were  caused  by  fungi,  43%  mycobacteria,
c
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tculture-negative PJI.
nd  11%  were  caused  by  other  bacteria  such  as
isteria  monocytogenes,  Propionibacterium  acnes,
taphylococcus, Streptococcus, Brucella,  Coxiella
urnetii,  and  Tropheryma  whipplei  as  shown  in
able  1.2  [8,17,20—24]. In  31  cases  of  atypi-
al culture-negative  infections  studied,  35%  were
eported  as  Brucella  and  16%  was  Coxiella  burnetii,
xcluding all  cases  of  fungi  and  mycobacteria  [26].
C. burnetti  is  one  example  of  treatment  fail-
re that  will  result  in  multiple  revision  surgeries
f left  undiagnosed  that  has  been  studied  more
ecently.  Million  et  al.  showed  that  the  current
tandard culture  methods  for  PJI  missed  three  out
f four  cases  of  positive  C.  burnetti  cases  that  were
orrectly  detected  with  polymerase  chain  reaction
PCR)  [26].  PCR  was  done  in  these  cases  due  to
typical presentations  on  imaging  that  suggested  a
erious infection  that  was  previously  missed.  Mil-
ion et  al.  proposed  that  all  culture-negative  cases
hould be  worked  up  speciﬁcally  for  C.  burnetti  and
rucella  serology  with  PCR.
These organisms  are  similar  to  those  that
re found  to  cause  culture-negative  endocardi-
is. Chlamydia  and  Bartonella  are  associated  with
ulture-negative  endocarditis,  but  have  not  been
reviously  reported  in  culture-negative  PJI  [17].
Pasteurella  multocida,  Lactobacillus  spp.,  Ure-
plasma parvus,  and  Serratia  marcescens  have  also
een found  to  cause  PJI  that  are  more  difﬁcult
o diagnose  and  associated  with  PJI  with  negative
ultures [20—23,27].  Failure  to  properly  identify
he microorganism  results  in  failure  to  treat  or
mproper  treatment,  and  subsequently  increases
he chances  of  treatment  failure  [27]. Bacteria
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such  as  Staphylococcus  aureus,  coagulase-negative
staphylococcus,  and  Pseudomonas  spp.  are  known
to form  a  bioﬁlm,  which  subsequently  makes  the
organisms  difﬁcult  to  detect  routinely  [24].
Treatment failure  is  a  problem  for  PJI  with
negative cultures  because  standard  cultures  and
traditional  empiric  treatment  will  not  eliminate
other organisms,  such  as  resistant,  zoonotic,  fas-
tidious, or  fungi.  This  has  been  studied  with  the
commonly  used  empiric  treatment  of  vancomycin
that has  not  been  effective  in  eliminating  culture-
negative endocarditis  infections  caused  by  these
atypical  pathogens  [17]. Surgical  and  medical  treat-
ments must  be  tailored  to  these  organisms  to
effectively clear  the  infection.
Risk factors
Demographic  risk  factors  for  culture-positive  and
PJI with  negative  cultures  infections  are  similar  and
reported in  Table  2.1  [9,26,28].  These  include  a
slightly higher  incidence  rate  in  men  older  than
65 years  with  a  BMI  greater  than  25  that  present
with multiple  comorbidities  or  in  a  chronic  immuno-
suppressive  state  [9,26,28].  Peel  reported  a 10%
increase  in  risk  of  infection  is associated  with
every 1  kg/m2 increase  in  BMI  with  a  signiﬁcant
p-value of  0.05.  Compounding  comorbidities  asso-
ciated with  an  increased  risk  for  PJI  include  chronic
steroid use,  chronic  renal  insufﬁciency  (creatinine
clearance <30  mL/min),  degenerative  joint  disease,
rheumatoid  arthritis,  other  diseased  joint  states,
diabetes  mellitus,  liver  disease,  poor  nutritional
status (albumin  <34  g/L  or  absolute  lymphocyte
count <1.5  ×  109/L),  smoking,  and  any  recent  infec-
tions within  30  days  of  surgery  [1,5,9,13,29].  Maier
et al.  found  a  signiﬁcant  relationship  between  vita-
min D  deﬁciency  and  PJI  with  a  p-value  of  <0.001
[30].  All  of  these  risk  factors  are  associated  with  a
decrease in  the  body’s  ability  to  ﬁght  infection  and
heal properly.
Previous  revision  surgeries,  superﬁcial  surgi-
cal site  infections,  wound  drainage,  surgical  time
longer than  2.5  h,  and  an  increased  American  Soci-
ety of  Anesthesiology  (ASA)  index  are  other  risk
factors  that  have  been  found  to  be  associated  with
PJI. ASA  index,  wound  drainage,  and  surgical  site
infections  were  found  to  be  statistically  signiﬁcant,
with p-values  of  0.05,  0.001,  and  0.007,  respec-
tively [4,31].In  addition  to  the  risk  factors  for  all  PJI,  the
major risk  factor  for  PJI  with  negative  cultures  is
related to  prior  antibiotic  use.  In  a  previous  study
in 2010,  64%  of  135  culture-negative  patients  were
b
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ound  to  have  used  antibiotics  within  3  months  prior
o their  culture-negative  diagnosis  and  13%  receiv-
ng their  last  dose  one  week  prior  [8]. In  the  same
tudy,  Malekzadeh  et  al.  found  that  postoperative
ound drainage  was  more  likely  to  be  associated
ith PJI  with  negative  cultures  as  compared  to
ulture-positive.  Prior  antibiotic  use  and  a post-
perative  wound  drainage  were  both  found  to  be
tatistically  signiﬁcant  with  a  p-value  of  <0.001  [8].
 history  of  prior  prosthetic  joint  infections  were
ound  to  be  associated  with  19%  of  culture-negative
nfections,  while  only  8%  of  culture-positive  infec-
ions were  associated  with  a  prior  PJI,  with  a
-value of  0.008  [8].
In a study  by  Berbari  et  al.  that  investigated  sixty
ulture-negative  cases,  53%  received  antibiotics
ithin the  last  3  months  with  44%  receiving  antibi-
tics at  the  time  of  tissue  culture.  The  absence
f acute  inﬂammation  histologically  was  found  to
e associated  with  an  increased  risk  of  treatment
ailure, with  a p-value  of  <0.001  [28]. Peel  et  al.
howed that  out  of  nineteen  culture-negative  cases
tudied, 92%  of  patients  received  antibiotics  within
ne week  of  their  culture  [30].  Trampuz  et  al.
eported  that  antibiotic  use  within  2  weeks  of  diag-
osis decreased  the  sensitivity  of  positive  cultures
nd supports  the  need  to  address  the  current  rec-
mmendation  for  prophylactic  antibiotic  use  as  a
arge risk  factor  for  a  culture-negative  diagnosis
1,31].
The method  of  culture  and  the  number  of  cul-
ures obtained  are  risk  factors  that  should  also  be
onsidered.  PJI  with  negative  cultures  are  thought
o be  caused  by  misdiagnosis,  antibiotic  use  as  pre-
iously described,  usage  of  inappropriate  media,
nadequate  incubation  time,  and  loss  of  viability
elated  to  transport  [8,25]. The  study  showed  that
iscontinuing  antibiotics  2  weeks  prior  to  cultures
igniﬁcantly  impacts  the  sensitivities  and  diagnosis
8,25]. Tissue  culture  sensitivity  increases  with  an
ncreased incubation  time  and  when  at  least  5  cul-
ures are  obtained.  An  incubation  time  of  at  least
0—14 days  has  been  shown  to  identify  slow  growing
Propionibacterium  acnes)  and  fastidious  organisms
hat are  often  misdiagnosed  if  not  incubated  for  the
roper amount  of  time  [27,32].  DeHaan  suggested  a
ew protocol  for  culture-positive  PJI  that  called  for
n increased  incubation  time  and  increased  num-
er of  cultures  to  be  obtained.  In  his  study,  21%  of
issed  virulent  organisms  by  routine  methods  were
roperly  identiﬁed  by  his  suggestive  approach,
liminating these  cases  that  would  have  otherwise
een identiﬁed  as  false  positive  culture-negative
JI [32]. He  was  also  able  to  successfully  identify
rue culture-negative  cases  as  sterile  joints  in  95%
f cases  [32].
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Table  2.1  Demographics  and  risk  factors  for  culture-negative  PJI  [9,26,28].
Gender  Male  53—58%
Age  >65  >50%
BMIa >25  >50%
Comorbidities  •  Chronic  renal  insufﬁciency  5%
•  Degenerative  joint  disease  53%
•  Rheumatoid  arthritis  15—20%
•  Other  joint  problem  (congenital,  avascular  necrosis,  septic  arthritis,
psoriatic  arthritis,  malignancy)
<5%
•  Diabetes  mellitus 8—12%
• Liver  disease  3%
•  Vascular  insufﬁciency  7%
Immunosuppression  •  Malignancy  17—21%
•  Chronic  steroid  use  11—18%
Other  •  Median  joint  age  746  days
•  Prior  antibiotic  use  53—64%
•  History  of  PJI  or  surgical  site  infection  3—8%
•  Previous  revision  surgery  5%
every
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ta There is a 10% increased risk of infection associated with 
ioﬁlm
ioﬁlms  are  deﬁned  as  thin  ﬁlms  that  adhere
o surfaces,  commonly  associated  with  implanted
evices, prostheses,  and  damaged  tissues  [23,24].
ioﬁlms are  formed  by  certain  bacteria  that  aggre-
ate together  and  produce  an  extracellular  matrix
llowing  for  the  adhesion,  evasion,  and  resistant
roperties that  make  these  organisms  difﬁcult  to
liminate.  These  bacteria  are  able  to  inactivate
roteins, alter  metabolism,  increase  resistance  to
ost immune  responses,  and  decrease  antibiotic
ffectiveness in  a  stationary  growth  phase  [33,34].
Many other  diseases  such  as  endocarditis,  peri-
dontitis,  surgical  site  infections,  and  catheter
elated infections  are  all  associated  with  bioﬁlm-
ausing organisms.  Planktonic,  free  living,  bacteria
re easily  eliminated  by  the  host  immune  response
nd antibiotic  therapy,  while  the  majority  of  pros-
hetic infections  are  caused  by  bioﬁlm  forming
acteria [33,34]. These  bacteria  are  in  a  stationary
rowth phase  that  allows  for  increased  resistance
o host  responses  and  antibiotic  therapy  [33,34].
pproximately  80%  of  all  PJIs  are  associated  with
acteria  that  form  a  bioﬁlm,  rather  than  planktonic
acteria that  are  readily  detected  diagnostically
6].
Staphylococcus  aureus  and  coagulase-negative
taphylococcus  most  commonly  develop  a  bioﬁlm
6].  However,  it  seems  that  the  quality  of  bioﬁlm
ormed by  different  bacteria  varies  by  species
nd speciﬁc  strains  and  this  may  also  be  a com-
ounding factor.  Standard  antibiotic  therapy  is
ffective in  treating  the  symptoms  associated  with
ioﬁlm-causing  organisms,  but  are  often  unable
n
m
r 1 kg/m2 increases in BMI with a p-value of 0.05 [26].
o  eliminate  the  bacteria.  This  is  because  the
acteria  produces  aggregates  that  form  a barrier
nd depletes  metabolic  nutrients,  causing  it  to  be
00—1000 times  more  resistant  to  phagocytic  host
efenses  and  antibiotic  treatments  than  planktonic
acteria  [1,10,33,34]. This  mechanism  of  resis-
ance allows  the  bacteria  in  the  bioﬁlm  to  evade
he host  defense  and  causes  a  delay  in  the  clinical
resentation with  a  worse  prognosis  due  to  the  lack
f a  systemic  response  produced  [1,10,33,34].
Zimmerli et  al.  described  several  studies  that
howed that  bioﬁlm-forming  bacteria  were  signif-
cantly  more  resistant  to  phagocytosis  and  host
ell responses.  Greater  than  95%  of  Staphylococcus
ureus survived  exposure  to  neutrophils  when  com-
ared with  planktonic  Staphylococcus  in  the  same
nvironment  [7]. Coagulase  negative  staphylococ-
us was  also  found  to  have  a  67%  survival  rate  when
ompared  to  identical  cloned  planktonic  Staphylo-
occi with  only  a  21%  survival  rate  [7].
S. aureus  (coagulase  negative)  is  the  most  com-
on organism  in  PJI.  It  is  dependent  on  host  tissue
roteins  such  as ﬁbronectin,  ﬁbrinogen,  laminin,
nd  collagen  for  adhesion  to  the  prosthesis  surface
hat allows  for  increased  resistance.  This  could  be  a
otential target  for  therapy  in  the  future  if  we  are
ble to  prevent  adhesion  and  subsequent  bioﬁlm
ormation  in  PJIs  [1,11].
Zimmerli et  al.  showed  that  a  foreign  body,  such
s an  implant,  decreased  the  minimal  infecting
ose of  S.  aureus,  allowing  for  an  increased  infec-
ion rate  and  failure  rate.  Only  100  colonies  were
eeded  to  infect  95%  of  implants  in  the  animal
odels [7]. Colonization  of  prosthetic  devices  is
elated to  the  microorganism,  decreased  quantities
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needed  to  cause  infection,  and  the  production  of  a
bioﬁlm. These  combined  all  pose  a  risk  for  PJI  with
negative  cultures  that  are  difﬁcult  to  detect  with
routine  culture  methods.  Granulocytes  that  would
normally  clear  the  infection  accumulate  around  the
implant and  are  unable  to  phagocytize  the  bioﬁlm
producing  bacteria  that  are  adhered  to  the  implant.
This causes  degranulation  and  inﬂammation  due
to a  ‘‘frustrated  phagocytosis  response’’  that  will
persist until  the  infection  is  successfully  cleared
[5,7,35].
Clinical picture
Prosthetic  joint  infections  with  negative  cultures
have been  found  to  present  as  early  infections
in the  elderly  as  compared  to  Gram-positive  PJI
[4].  Early  PJI  present  with  acute  inﬂammatory
responses  including  pain,  swelling,  erythema,  and
drainage  in  many  cases  [4,31]. Staphylococcus  bac-
teremia from  a  distant  site  poses  a  risk  PJI  in  about
34% of  patients  [4].  Chronic  infections  present  with
less signs  of  acute  inﬂammation  and  are  often  char-
acterized  by  chronic  pain  and  loosening  of  the  joint
[4].
For  this  group  of  patients,  history  is  critical
if clinical  signs  and  symptoms  are  not  evident.
Assessing the  patient’s  surgical  history,  previous
infections,  comorbidities,  and  recent  antibiotic  use
are all  important  in  the  diagnosis.
The demographics  for  culture-positive  and
culture-negative  joint  infections  are  similar.  An
overweight  male,  older  than  65  years,  with  multiple
comorbidities,  immunosuppression,  and  a history
of previous  revision  is  the  typical  clinical  picture
for culture-negative  PJI  as  shown  in  Table  2.1
[9,26,28].  This  is  nonspeciﬁc  and  patients  pre-
senting  outside  these  demographics  should  not  be
excluded.
Factors that  predispose  patients  to  negative
cultures depend  upon  the  culture  method  and
diagnosis.  Routine  cultures  are  signiﬁcantly  less
sensitive  than  cultures  with  an  increased  incubation
time of  10—14  days  and  when  at  least  5 cultures  are
obtained  as  suggested  by  Dehaan’s  protocol  [32].
Tissue cultures  can  be  falsely  negative  due  to  the
location  of  the  culture  and  how  it  was  obtained.
An increased  incidence  of  negative  cultures  has
been found  directly  around  the  joint  [36]. A  lack  of
access to  proper  diagnostic  tools,  such  as  the  facil-
ity for  sonication  and  PCR  of  explanted  prostheses
to detect  the  organism  can  also  predispose  to  a
culture-negative  diagnosis  and  should  be  made  note
of when  considering  a  culture-negative  infection.
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Parvizi  et  al.  showed  that  the  current  diagnostic
ools of  tissue  and  ﬂuid  cultures  displayed  a  false
ositive rate  up  to  37%  and  a  false  negative  up  to
8% [19]. A  review  of  651  cases  of  PJI  compared
ulture-positive  cases  to  48  cases  of  culture-
egative found  and  concluded  that  the  traditional
ulture methods  failed  to  isolate  the  correct
icroorganism  when  it  came  to  fungi,  fastidious,
r zoonotic  organisms  causing  the  infection  [19].
iagnostic approach
nﬂammatory markers
-reactive  protein  (CRP)  and  erythrocyte  sedimen-
ation  rate  (ESR)  levels  are  non-speciﬁc  indicators
f inﬂammation  and  should  be  evaluated  serially  in
he diagnosis  of  PJI  as  a more  accurate  indicator
f the  inﬂammatory  trend.  CRP  and  ESR  are  often
aised in  PJI,  as  well  as  many  other  conditions,
nd is  elevated  post-surgery  for  several  weeks  [11].
ereza et  al.  showed  that  the  CRP  level  correlated
ith the  number  of  positive  cultures.  A  CRP  level
reater  than  10  mg/l  was  seen  in  every  PJI  case
tudied [36].
A  synovial  ﬂuid  analysis  of  polymorphonuclear
PMN)  cell  count  showed  a sensitivity  of  90%  and
peciﬁcity  of  88%  to  detect  PJI  [37].  Trampuz  et  al.
howed that  a  synovial  ﬂuid  leukocyte  count  of
reater than  1.7  ×  109/L  had  a  sensitivity  of  94%
nd speciﬁcity  of  88%  [1,11]. Normal  wear  of  pros-
heses overtime  can  also  cause  an  inﬂammatory
eaction that  results  in  osteolysis  and  a granulo-
atosis reaction  that  can  lead  to  bone  resorption
nd loosening  of  the  prosthesis.  As  a result,  ESR  and
RP will  increase,  but  is  not  necessarily  due  to  an
nfectious  cause  [38]. Bracken  et  al.  showed  that
nﬂammatory  markers  combined  with  synovial  ﬂuid
spiration  and  clinical  symptoms  did  not  differenti-
te infections  of  bacterial  versus  fungal  origin  [15].
istopathology
he  use  of  histopathology  can  help  to  conﬁrm  the
resence  and  extent  of  inﬂammation  with  a  sen-
itivity  of  greater  than  80%  and  a  speciﬁcity  of
reater than  90%  in  culture-positive  PJI  [1,11].
here are  no  current  guidelines  that  conﬁrm  the  use
f histopathology  in  culture-negative  PJI.  Berbari
t al.  reported  that  out  of  60  primary  cases  of
JI with  negative  cultures  78%  displayed  acute
nﬂammation on  histopathological  exam  [28].  A
ynovial tissue  biopsy  must  be  obtained  in  order
o send  the  suspected  periprosthetic  material  for
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istopathology  evaluation.  This  can  be  achieved
outinely to  aid  in  the  diagnosis  of  culture-negative
JI.
maging
maging  modalities,  such  as  plain  ﬁlms,  computed
omography (CT),  and  magnetic  resonance  imaging
MRI) are  nonspeciﬁc  for  all  PJI,  and  will  not  specif-
cally  aid  in  the  diagnosis  of  culture-negative  PJI.
hese images  can  help  to  determine  the  current
tate of  the  joint  by  showing  changes,  loosening,
uid collections,  or  signs  of  inﬂammation  [11,36].
inus tract  formation  and  the  new  formation  of
one are  speciﬁc  signs  seen  on  imaging  for  all  PJI
11].
Though  not  widely  used,  ﬂuorodeoxyglucose-
ositron  emission  tomography  (FDG-PET)  has  been
nvestigated  as  an  imaging  tool  in  diagnosing  PJI.
DG-PET  has  been  found  to  have  a  sensitivity  of  82%
nd speciﬁcity  of  87%  [37]. It  should  be  noted  that
DG uptake  can  be  increased  post-surgery  for  up
o 6 months.  It has  also  been  associated  with  bone
ractures  and  atherosclerotic  lesions  [10].
Antigranulocyte  scintigraphy  has  also  been  stud-
ed in  PJI  and  was  found  to  have  a  sensitivity  of  83%
nd speciﬁcity  of  80%  for  detecting  tissue  inﬂamma-
ion. Technetium-99m  scans  have  also  been  found
o have  an  accuracy  rate  of  81%  in  detecting  PJI
1,11].  The  combined  use  of  labeled  leukocyte
maging and  Technetium  99m  labeled  sulfur  colloid
ay have  a  higher  diagnostic  yield.
iagnostic methods
eri-prosthetic cultures
he  current  diagnostic  criteria  from  the  Infectious
iseases Society  of  America  updated  in  2013  deﬁnes
 prosthetic  joint  infection  as  having  one  of  the
ollowing:  presence  of  a  sinus  tract  communica-
ion with  the  prosthetic  joint,  purulence  without
 known  cause  surrounding  the  prosthetic  device,
cute inﬂammation  on  histopathological  exami-
ation  of  periprosthetic  tissue  consistent  with
nfection,  synovial  ﬂuid  with  leukocytosis  and/or
ith the  predominance  of  neutrophils,  or  growth
f identical  microorganisms  in  at  least  two  intraop-
rative  cultures  [7—9,39].
In the  case  of  a  low  virulent  microorgan-sm,  such  as  coagulase  negative  staphylococci
r Propionibacterium  acnes,  a  combination  of
reoperative  aspiration  and  intraoperative  cul-
ures are  necessary  to  make  a  diagnosis.  If  the
m
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rganism  has  increased  virulence,  such  as  S.  aureus
r Escherichia  coli,  a  single  specimen  growth  in
ither synovial  ﬂuid,  periprosthetic  tissue  culture,
r sonication  ﬂuid  with  at  least  one  other  criterion
bove must  be  met  to  be  classiﬁed  as  a prosthetic
oint infection  [28,39,40].
PJI with  negative  cultures  were  originally
eﬁned by  Berbari  as  no  growth  of  either  aero-
ic or  anaerobic  cultures  taken  from  periprosthetic
issue with  either  the  presence  of  peripros-
hetic purulence,  presence  of  acute  inﬂammation
istopathologically,  or  a sinus  tract  communicating
ith the  prosthesis  [9,28,29,41].  There  is  currently
o gold  standard  for  diagnosis  of  PJI  or  speciﬁ-
ally culture-negative  PJI.  Many  diagnostic  tools  are
eing researched  to  determine  their  accuracy  when
pplied  to  PJI  to  deﬁne  a  more  reliable  method  than
hat is  currently  used  [37].
A recent  study  showed  that  46%  of  111  PJI  cases
ere found  to  be  classiﬁed  as  early,  22.5%  delayed,
nd 31.5%  late  [6,11]. This  shows  the  importance
f a  rapid,  accurate  diagnosis.  Due  to  the  dif-
culty of  diagnosing  culture-negative  PJI,  a full
linical evaluation  and  workup  should  be  imple-
ented  to  determine  the  diagnosis.  This  includes  a
omplete patient  history,  clinical  evaluation,  labo-
atory tests,  and  imaging  to  rule  out  other  diagnoses
1,36].  Pasticci  et  al.  recommended  that  a full
icrobial  investigation  should  become  the  standard
rotocol  regardless  of  negative  laboratory  or  imag-
ng ﬁndings  in  any  previous  or  suspected  case  of  PJI
40].
onication of explanted implant
icroorganisms  that  aggregate  and  form  a  bioﬁlm
hat adheres  to  prostheses  can  be  disrupted  by
onication  of  explanted  prostheses  to  increase  the
ensitivity  of  the  culture.  These  bacteria  are  in
he stationary  phase  and  can  be  broken  down  into
lanktonic  bacteria  that  are  easily  detected  [36].
Trampuz  et  al.  showed  that  sonication  of
xplanted prostheses  had  a 78.5%  sensitivity  and
8.8% speciﬁcity.  Tissue  culture  without  sonication
as shown  to  have  a  60.8%  sensitivity  and  99.2%
peciﬁcity, with  a  p-value  of  <0.001.  Sensitivities
or both  tissue  and  sonicated  cultures  were  still
ecreased  in  patients  who  received  antibiotics  2
eeks prior  to  culture  [31].
Sonication of  temporary  spacers  that  are
emoved in  2-stage  revision  is  a predictor  of
einfection and  is  associated  with  a  50%  treat-
ent failure  rate  when  results  are  positive  within
4 months  [42,43].  Small  colony  variants  of
. aureus  and  coagulase-negative  staphylococ-
us are  also  difﬁcult  to  detect  with  traditional
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diagnostic  approaches  and  often  asymptomatic
leading to late  infections.  Sonication  is  able  to
detect these  small  colony  variants  and  should  be
considered  in  all  culture-negative  infections  [8,44].
PCR (molecular methods)
Synovial  ﬂuid  analysis  through  PCR  (molecular
method using  brad  spectrum  PCR-16s  rDNA)  and
mass spectrometry  has  been  shown  to  have  a sen-
sitivity  of  81%  and  a  speciﬁcity  of 95%  for  PJI  and  is
able to  detect  greater  than  3400  types  of  bacteria.
Melendez et  al.  proved  this  diagnostic  approach  to
be valuable  by  detecting  microorganisms  in  synovial
ﬂuid in  88%  of  patients  diagnosed  with  aseptic  pros-
thetic failure.  This  method  can  be  used  to  detect
forty  species  of  Candida  and  four  common  antibi-
otic  resistant  genes,  including  mecA  for  MRSA,  vanA
& B,  and  bla  KPC  [44].  This  was  supported  by  the
use of  PCR  with  mass  spectrometry  that  was  shown
to isolate  four  out  of  ﬁve  culture-negative  cases
with increased  sensitivity  for  these  resistant  genes
[16].  Bereza  et  al.  showed  that  bacterial  DNA  was
isolated  with  PCR  in  90%  of  patients  with  negative
synovial ﬂuid  cultures  [36].
PCR of  tissue  cultures  have  been  shown  to  have
an overall  sensitivity  of  50—86%  [10].  In  a previ-
ous study,  PCR  analysis  of  sonicated  cultures  of
explanted  prostheses  yielded  a  72%  detection  rate
compared  to  22%  sonication  only,  and  4%  tradi-
tional cultures  [2]. In  a  similar  study,  it  was  found
that the  sensitivity  of  PCR  of  sonicated  cultures
in patients  with  previous  antibiotic  use  was  42%,
but was  100%  when  PCR  of  sonicated  ﬂuid  with  a
p-value of  0.001  [10]. Sonication  combined  with
PCR increases  the  sensitivity  in  detecting  PJI  with
negative  cultures  with  atypical  organisms,  bioﬁlms,
small colony  variants,  and  in  those  patients  who
have received  antibiotics  previously  [36,44].
Sonication combined  with  molecular  based
methods, such  as  PCR,  should  be  implemented
in the  future  as  research  continues  to  show  the
accuracy  in  detecting  culture-negative  PJI.  Speciﬁc
resistance  genes,  such  as  mecA  for  MRSA,  should
also be  considered  in  the  management,  diagnosis,
and  as  a  possible  target  for  these  patients  [45].
Treatment failure
The  risk  of  infection  with  the  presence  of  a for-
eign body,  such  as  prosthesis,  is  greater  than
100,000 fold  as  studied  in  animal  models  compar-
ing infection  rates  with  prosthetic  implants  [8,35].
This increased  risk  of  infection,  combined  with  an
increased resistance  of  bacteria,  and  difﬁculty  iso-
lating certain  organisms  addresses  a  need  for  a
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roposed  guideline  and  a  standard  approach  for  the
roper diagnosis  and  treatment  for  PJI  with  nega-
ive cultures.
Berbari  et  al.  showed  that  in  ten  cases  of
JI treatment  failure,  50%  were  culture-negative
nfections  [28]. These  patients  had  a  29%  failure
ate when  treated  with  retention  and  incision  and
rainage  (I&D)  of  the  prosthesis  compared  to  only  a
% failure  rate  when  two-stage  revision  was  per-
ormed  [28]. A  similar  study  showed  that  with
ulture-negative infections,  treatment  failure  was
0% with  I&D  and  29.6%  with  two-stage  revision
25]. Malekzadeh  et  al.  showed  that  these  patients
ad a 22%  two-year  failure  rate  with  I&D  compared
o a  14%  failure  rate  with  I&D  in  culture-positive
JI [8]. These  studies  showed  that  culture-negative
nfections exhibit  a poor  response  to  therapy
ithout the  use  of  one  or  two-stage  revision,
hich is  necessary  to  completely  eradicate  the
nfection.
This can  be  compared  with  the  MSSA  failure  rate
hen treated  with  I&D  that  has  been  found  to  be
6.7% and  only  8.5%  with  two-stage  revision  [10].
RSA has  a  failure  rate  of  51.1%  with  I&D  and  27.8%
ith two-stage  exchange.  Gram-negative  infec-
ions treated  with  I&D  and  retention  were  found
o have  a failure  rate  of  30%  and  25%  with  two-
tage revision  [10]. Failure  rates  related  to  fungal
nfections  were  50%  when  treated  with  two-stage
evision [10].
The  increased  failure  rates  related  to  Gram-
ositive infections  as  compared  to  Gram-negatives
re thought  to  be  related  to  the  increased  resis-
ance,  low  levels  of  colony  forming  units  causing
nfections, and  the  bioﬁlm  production  more  com-
only associated  with  Gram-positive  bacteria  [46].
n contrast,  Aboltins  et  al.  showed  a favorable  fail-
re rate  for  I&D  of  6%  when  treated  with  an  oral
uoroquinolone for  a median  duration  of  12  months
2]. This  suggests  that  once  the  correct  pathogen
s identiﬁed  in  a culture-negative  diagnosis,  there
an be  a  favorable  outcome  when  the  correct
ntibiotic therapy  and  surgical  management  are
pplied.
reatment
he  classiﬁcation  of  PJI’s  is  important  to  consider
hen determining  treatment  management.  Early
nfections  occurring  within  3  weeks  post-surgical
an be  treated  with  retention  of  the  prosthe-
is and  antibiotic  therapy  with  a success  rate  of
0—90% [10]. It  is  recommended  that  the  pros-
hesis be  removed  for  delayed  and  late  infections
o effectively  eliminate  the  infective  bioﬁlm.  This
ighlights  the  need  for  rapid  diagnosis  for  all  PJIs
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ianagement  of  culture  negative  prosthetic  joint  in
o  allow  the  patient  to  retain  their  prosthesis  and
e treated  successfully  [40]. Unfortunately,  the
urrent  literature  does  not  speciﬁcally  address  the
anagement  for  culture-negative  PJIs.
In a  one-stage  revision,  the  infected  prosthesis
s removed  and  replaced  with  a  new  sterile  pros-
hesis at  that  time.  The  most  common  treatment
nd gold  standard  for  all  PJIs  is  the  two-stage  revi-
ion [46].  In  a  two-stage  exchange,  the  prosthesis
s removed  and  either  replaced  with  an  antibiotic-
oated spacer  or  left  without  any  device  until
he infection  is  cleared  with  antibiotic  treatment.
nce the  infection  is  eliminated,  the  prosthesis
s replaced.  It  has  been  shown  that  one-stage
evision has  an  86—92%  success  rate  and  two-
tage has  a  75—100%  success  rate  in  eliminating
ulture-positive  infections  [40,47].  Two-stage  revi-
ion followed  by  6  weeks  of  antibiotic  therapy  has
een shown  to  be  successful  at  all  stages  of  PJI
ith 94.4%  early,  93.8%  delayed,  and  94.5%  of  late
nfections  being  eliminated  [47].
PJI  with  negative  cultures  have  been  found  to
ave a  50%  failure  rate  with  I&D  compared  to  29.6%
ailure rate  with  2-stage  [40].  This  illustrates  the
hallenges  in  management  and  need  for  revision  to
radicate  resistant,  fungal,  or  atypical  organisms
ssociated  with  culture-negative  infections.
ntibiotic therapy
ong-term  antibiotic  use  in  addition  to  surgical
ntervention is  necessary  to  effectively  eliminate
nfection in  a  PJI  with  negative  cultures.  Bacteria
hat produce  a  bioﬁlm  remain  in  the  slow  growth,
tationary phase.  For  an  antibiotic  treatment  to  be
uccessful  in  eliminating  these  organisms,  it  must
ave a  higher  than  normal  minimal  bactericidal
oncentration.
Current recommendations  for  culture-positive
JI in  the  hip  and  knee  suggest  3 or  6  months
f antibiotic  therapy  based  on  the  organism  iden-
iﬁed in  addition  to  2-stage  revision.  Rifampin
as been  shown  to  disrupt  the  bioﬁlm  produced
y Staphylococcus  and  is  recommended  in  com-
ination  with  a  ﬂuoroquinolone  for  use  against
ram-negative bioﬁlm-producing  bacteria  [10,40].
ue to  the  increased  failure  rate  associated  with
RSA infections,  an  alternative  for  treatment
ould include  rifampin  plus  vancomycin  or  linezolid
10].  These  current  recommendations  for  culture-
ositive infections  can  also  be  applied  to  PJI  with
egative  cultures  if  suspicion  for  culture-negative  is
igh and  thought  to  be  related  to  these  organisms
ut were  not  properly  isolated.
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roposed algorithm
here  are  no  current  guidelines  that  exist  to  out-
ine the  diagnostic  methods  and  management  of  PJI
ith negative  cultures.  It  is  important  to  accurately
iagnose all  prosthetic  joint  infections  by  chang-
ng the  current  protocol  that  calls  for  only  synovial
uid and  tissue  culture  required  for  diagnosis  for
JI.
For this  reason,  it  has  been  shown  that  the  pro-
uction of  a  bioﬁlm  is  an  independent  risk  factor  for
reatment failure  and  is  a  cause  of  culture-negative
JI [5]. For  this  reason,  we  suggest  that  sonication
f explanted  prostheses  is a  method  that  should
e routinely  employed  to  detect  bioﬁlm-associated
acteria to  aid  in  the  diagnosis  of  culture-negative
JI.
In a  study  by  Bereza  et  al.  using  ultrasound,
onication  and  PCR  to  detect  bacteria  associated
ith loosening  of  hardware  in  PJI,  he  reported  that
ltrasound  and  sonication  were  the  best  diagnostic
ools used  on  explanted  devices  to  detect  speciﬁc
icroorganisms.  Ultrasound  and  sonication  are  able
o disrupt  bioﬁlms,  forcing  stationary  bacteria  into
n active  phase  that  is  easily  detected.  He  also
howed  that  when  combined  with  PCR,  the  sensi-
ivities of  culture  signiﬁcantly  increased  with  these
iagnostic  methods  [36].
We suggest  a  different  approach  in  this  group
hat will  help  guide  physicians  in  the  diagnosis  and
anagement  of  these  infections  as  illustrated  in
able  3.1.
First, we  suggest  an  increase  in  the  number
f cultures  and  incubation  time  for  all  cultures
btained, with  a  minimum  of  ﬁve  cultures  as
uggested  by  DeHaan  et  al.,  in  addition  to  a
istopathological examination  [32]. Fungal  and
typical cultures  (AFB)  should  be  obtained  in  all
ases, as  studies  have  shown  routine  blood,  tissue,
nd synovial  ﬂuid  cultures  will  not  detect  or  dif-
erentiate  these  organisms  [15]. We  also  suggest
hat sonication  and  PCR  of  the  explanted  pros-
hesis be  performed  in  all  culture-negative  cases
r when  clinical  suspicion  is  high  for  an  atyp-
cal diagnosis.  Inﬂammatory  markers  (ESR/CRP)
hould then  be  monitored  serially  every  month
or 2 years,  as  studies  have  shown  the  risk  for
JI is  the  highest  in  the  ﬁrst  2  years  post-surgery
1,2].
When  suspicion  or  diagnosis  for  culture-negative
JI is  high,  we  propose  that  the  following  algorithm
n Table  3.1  be  employed.  We  use  the  deﬁni-
ion of  PJI  with  negative  cultures  as  deﬁned  by
erbari et  al.  [28]. Symptomatic  is  deﬁned  as  acute
nﬂammatory  signs  and  symptoms  of  fever,  pain,
enderness,  erythema,  warmth,  swelling,  effusion,
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Table  3.1  Suggested  algorithm  for  culture-negative  PJI.
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tand  purulence  at  the  surgical  site.  Purulence,  pain,
and erythema  were  found  to  be  the  most  common
presenting symptoms  [4,11,26].
The  negative  synovial  ﬂuid  and  tissue  cultures
should follow  Dehaan’s  suggestion  with  a mini-
mum of 5  cultures  taken  with  extended  incubation
time to  increase  the  sensitivities  of  the  cultures
and diagnosis  of  slower  growing  bacteria  that  is
often missed,  such  as  Propionibacterium  acnes.
In all  cases,  we  recommend  the  next  step  being
a full  diagnostic  workup  to  determine  only  the
true-positive cases  of  culture-negative  PJI.  A  full
diagnostic  workup  would  include  additional  fun-
gal and  acid  fast  cultures,  acid  fast  bacilli  (AFB)
PCR, PCR  of  the  all  cultures,  Brucella  and  Coxiella
d
t
oerologies,  histopathological  evaluation,  and  serial
nﬂammatory  markers  (ESR/CRP).
For symptomatic  patients,  if  any  of  the  diag-
ostic workup  that  is  implemented  is positive  or
as indeterminate  results  with  signs  or  symptoms
uggestive of  a  PJI,  but  do  not  completely  fulﬁll
he criteria  for  clinical  infection  on  the  diagnostic
orkup, we  suggest  that  a revision  (one  or  two-
tage)  with  sonication  cultures  of  the  explanted
rosthesis be  performed  in  addition  to  combined
CR (broad  spectrum)  of  the  sonicated  cultures
o further  increase  the  diagnostic  sensitivities  in
etecting the  organism  causing  the  infection  with
he proper  concomitant  IV  or  intra-articular  antibi-
tics for  4—6  weeks  minimum.  After  revision,  we
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[anagement  of  culture  negative  prosthetic  joint  in
uggest  follow  up  in  6—8  weeks  with  aspiration  of
uid. If  the  ﬂuid  is  negative  at  that  time,  reimplan-
ation can  be  done  at  that  time  with  no  changes  in
reatment,  and  follow  up  as  necessary.  If  the  ﬂuid
s positive,  continue  with  the  current  treatment  or
onsider changing  the  spacer,  retreating,  and  follow
p in  6—8  weeks.
For patients  with  completely  negative  results  on
he full  diagnostic  workup,  we  suggest  follow  up
n 3—6  months  with  new  ESR/CRP  levels.  If  the
SR/CRP is  still  normal  at  that  time,  we  suggest
rending the  ESR/CRP  levels  every  3—6  months  for  2
ears due  to  the  increased  likelihood  of  infection  in
he ﬁrst  2  years  post-surgery,  and  without  revision
t this  time.
If the  ESR/CRP  are  found  to  be  increased,  a
ull diagnostic  workup  as  listed  above  should  be
mployed  again.  If  the  results  on  the  diagnostic
orkup are  again  negative,  we  suggest  continu-
ng to  trend  the  inﬂammatory  markers  (ESR/CRP)
very 3  months  for  2  years.  If  the  ESR/CRP  are
ith normal  limits  in  3  consecutive  tests  or  2  years
ost-operation has  been  reached  without  cause
or follow  up,  no  revision  or  further  evaluation  is
eeded.
If the  ESR/CRP  are  found  to  be  increased  or  if  any
f the  diagnostic  workup  at  that  time  is  found  to
e positive,  we  suggest  revision  with  sonication  of
he explanted  prosthesis  be  highly  considered  with
ollow up  ﬂuid  aspiration  in  6—8  weeks.
onclusion
JI  with  negative  cultures  accounts  for  10%  of  all
JIs, but  poses  a  serious  problem  in  regards  to  the
roper diagnosis  and  management.  The  approach
o these  infections  should  include  a  complete  and
horough  microbiological  evaluation  with  a mini-
um of  5  cultures  that  are  kept  for  several  weeks,
he use  of  newer  methods  for  the  identiﬁcation
f these  microbes  such  as  sonication,  DNA  PCR,
nd histopathology.  Successful  treatment  involves
xchange  arthroplasty  with  concomitant  antibiotic
reatment  based  on  the  possible  pathogen.
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